Clinical Trials Logo

Clinical Trial Summary

The primary objective of this study is to determine the safety and feasibility of 3,4-methylenedioxymethamphetamine (MDMA) -assisted psychotherapy to treat resistant post-traumatic stress disorder (PTSD). The secondary objectives are the exploration of effectiveness for treatment-resistant PTSD, symptoms of depression, and anxiety symptoms.


Clinical Trial Description

This study is an open-label fixed dose trial whereby youth with treatment-resistant post-traumatic stress disorder (PTSD) will be recruited. Treatment-resistant depression is defined as having continued Diagnostic Statistical Manual (DSM-5) diagnosis of PTSD following at least 3 months of psychotherapy and (either separately or combined) at least 3 months of SSRI pharmacotherapy. Before entering the trial, youth will undergo a preliminary medical and psychiatric screening to determine eligibility. Eligible youth will then proceed to 3-month MDMA-assisted psychotherapy, which includes 13 sessions of psychotherapy with two MDMA experimental medication sessions of 80mg and 120mg, respectively. Study assessments will include a baseline assessment, weekly assessments throughout the course of the treatment trial, and assessments at 3 months and 6 months post-treatment. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06353282
Study type Interventional
Source University of California, Los Angeles
Contact Jessica K Jeffrey, MD, MPH, MBA
Phone 310-825-5263
Email jjeffrey@mednet.ucla.edu
Status Not yet recruiting
Phase Phase 2
Start date July 1, 2025
Completion date December 31, 2026

See also
  Status Clinical Trial Phase
Completed NCT02912962 - Self-Regulation in Adolescents With FASD: The Efficacy of a Targeted Intervention N/A
Completed NCT01379924 - Young Parents Program, Project Connect N/A
Completed NCT04022642 - Effects of HIIT Integrated in PE Classes, on Physical Condition, Physical Activity and Motivation for Exercise N/A
Recruiting NCT04341064 - Sun-safe Habits Intervention and Education Phase 3
Withdrawn NCT01443949 - Teenagers, Drug Addiction, and Reward and Impulse Control
Recruiting NCT06254638 - Effectiveness of a Multicomponent Intervention to Promote Physical Activity Levels During the School Day (MOVESCHOOL) N/A
Completed NCT02561780 - Impact of a Mental Health Curriculum for High School Students on Knowledge and Stigma N/A
Active, not recruiting NCT05115422 - Feasibility and Acceptability of a Virtual 'Coping With Brain Fog' Intervention for Young Adults With Cancer N/A
Completed NCT03031197 - Supporting Adolescent Adherence in Vietnam (SAAV) N/A
Completed NCT01086670 - Physical, Functional and Neural Effects of Two Lower Extremity Exercise Protocols in Children With Cerebral Palsy Phase 1/Phase 2
Active, not recruiting NCT02697409 - Education Against Tobacco Randomized Trial N/A
Recruiting NCT01433692 - CANABIC : CANnabis and Adolescents, a Brief Intervention (BI) to Reduce Their Consumption N/A
Completed NCT04861116 - AcAdeMiC: Acting With Acceptance, Mindfulness and Compassion to Overcome Test/Exam Anxiety N/A
Completed NCT06253351 - Real-world Use of Hybrid Closed Loop in Adolescents and Young Adults 15-25 Years of Age With Type 1 Diabetes
Active, not recruiting NCT03287882 - Effect of Micronutrients and Life Skills Education on the Health and Nutrition of Adolescent and Young Women in Pakistan Phase 3
Terminated NCT02830334 - Use of the Ask Suicide-Screening Questions (ASQ) in Pediatric Outpatient Settings
Completed NCT03042234 - HIT in Insulin-resistant and Insulin-sensitive Obese Adolescents N/A
Recruiting NCT05086757 - Evaluation of Trauma Center-Based Intervention for Adolescent Traumatic Injury Survivors N/A
Active, not recruiting NCT05891054 - Effects of the Inclusion of Physical Activity in Secondary School Academic Classes: the ACTIVE CLASS Study N/A
Terminated NCT02050867 - Validation of the Ask Suicide-Screening Questions (ASQ) in the Inpatient Medical Setting